Kalehua Capital Management LLC: 13F holdings
CIK 21061812026Q2
| Positions | 26 |
|---|---|
| Reported value | $313.5m |
| Filed | 2026-08-19 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| Veradermics Inc | 291,390 | $35.8m | 11.4% |
| X4 Pharmaceuticals Inc | 7,445,680 | $34.8m | 11.1% |
| EA SERIES TRUST | 226,188 | $26.5m | 8.4% |
| Compass Pathways Plc | 1,639,384 | $23.2m | 7.4% |
| Surrozen Inc | 770,356 | $20.0m | 6.4% |
| ACRS Aclaris Therapeutics Inc | 3,664,730 | $19.4m | 6.2% |
| Sionna Therapeutics Inc | 394,144 | $17.3m | 5.5% |
| Inhibikase Therapeutics Inc | 7,643,780 | $15.5m | 4.9% |
| Pharvaris NV | 397,544 | $13.7m | 4.4% |
| Karyopharm Therapeutics Inc | 1,371,288 | $13.4m | 4.3% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2106181")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.